116 related articles for article (PubMed ID: 9751073)
1. Effects of oxatomide and derivatives on high affinity IgE receptor-activated signal transduction pathways in rat basophilic leukemia cells: role of protein tyrosine hyperphosphorylation and inhibition of extracellular calcium influx.
Paulussen JJ; Fischer MJ; Roozendaal RL; van der Heijden VC; van Dijken P; de Mol NJ; Janssen LH
Biochem Pharmacol; 1998 Sep; 56(6):693-701. PubMed ID: 9751073
[TBL] [Abstract][Full Text] [Related]
2. Influence of the anti-allergic drug oxatomide on the signal transduction mechanism in a mast cell model.
Paulussen JJ; Fischer MJ; Kok-Van Esterik JA; Tiemessen RC; De Mol NJ; Janssen LH
Eur J Pharmacol; 1996 Sep; 312(1):121-30. PubMed ID: 8891587
[TBL] [Abstract][Full Text] [Related]
3. Relation between effects of a set of anti-allergic drugs on calcium pathways and membrane structure in Fc epsilon RI activated signal transduction.
Fischer MJ; Paulussen JJ; Roozendaal R; Tiemessen RC; de Mol NJ; Janssen LH
Inflamm Res; 1996 Nov; 45(11):564-73. PubMed ID: 8951508
[TBL] [Abstract][Full Text] [Related]
4. Effects of the anti-allergics astemizole and norastemizole on Fc epsilon RI receptor-mediated signal transduction processes.
Fischer MJ; Paulussen JJ; Kok-Van Esterik JA; Van der Heijden VS; De Mol NJ; Janssen LH
Eur J Pharmacol; 1997 Mar; 322(1):97-105. PubMed ID: 9088877
[TBL] [Abstract][Full Text] [Related]
5. Dual effect of the anti-allergic astemizole on Ca2+ fluxes in rat basophilic leukemia (RBL-2H3) cells: release of Ca2+ from intracellular stores and inhibition of Ca2+ release-activated Ca2+ influx.
Fischer MJ; Paulussen JJ; de Mol NJ; Janssen LH
Biochem Pharmacol; 1998 Apr; 55(8):1255-62. PubMed ID: 9719481
[TBL] [Abstract][Full Text] [Related]
6. The delta isomer of hexachlorocyclohexane induces rapid release of the myo-inositol-1,4,5-trisphosphate-sensitive Ca2+ store and blocks capacitative Ca2+ entry in rat basophilic leukemia cells.
Mohr FC; Alojipan SV; Dunston SK; Pessah IN
Mol Pharmacol; 1995 Sep; 48(3):512-22. PubMed ID: 7565633
[TBL] [Abstract][Full Text] [Related]
7. Influence of the antiallergic drug oxatomide and derivatives on membrane structures: relation with inhibition of calcium influx in rat basophilic leukemia cells.
Paulussen JJ; Fischer MJ; Zuidam NJ; v Miltenburg JC; de Mol NJ; Janssen LH
Biochem Pharmacol; 1999 Mar; 57(5):503-10. PubMed ID: 9952313
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the nonlipophilic antiallergic drug eclazolast (REV 2871) in the inhibition of mediator release in a mast cell model.
Fischer MJ; de Mol NJ
Inflamm Res; 1999 Nov; 48(11):569-74. PubMed ID: 10598012
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of astemizole derivatives for inhibition of store operated Ca2+ channels and exocytosis.
Fischer MJ; Paulussen JJ; Tollenaere JP; De Mol NJ; Janssen LH
Eur J Pharmacol; 1998 Jun; 350(2-3):353-61. PubMed ID: 9696427
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of IgE-mediated phosphorylation of FcepsilonRIgamma protein by antiallergic drugs in rat basophilic leukemia (RBL-2H3) cells: a novel action of antiallergic drugs.
Hanashiro K; Sunagawa M; Nakasone T; Nakamura M; Kosugi T
Int Immunopharmacol; 2007 Jul; 7(7):994-1002. PubMed ID: 17499203
[TBL] [Abstract][Full Text] [Related]
11. Oxatomide and derivatives as inhibitors of mediator release from a mast cell model. Structure-activity relationships.
Paulussen JJ; Fischer MJ; Roelofsen EP; Horbach DA; de Mol NJ; Janssen LH
Arzneimittelforschung; 1996 May; 46(5):496-501. PubMed ID: 8737634
[TBL] [Abstract][Full Text] [Related]
12. Flotillin-1 regulates IgE receptor-mediated signaling in rat basophilic leukemia (RBL-2H3) cells.
Kato N; Nakanishi M; Hirashima N
J Immunol; 2006 Jul; 177(1):147-54. PubMed ID: 16785509
[TBL] [Abstract][Full Text] [Related]
13. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects.
Fischer MJ; Paulussen JJ; Horbach DA; Roelofsen EP; van Miltenburg JC; de Mol NJ; Janssen LH
Inflamm Res; 1995 Feb; 44(2):92-7. PubMed ID: 7655991
[TBL] [Abstract][Full Text] [Related]
15. Roles for Ca2+ stores release and two Ca2+ influx pathways in the Fc epsilon R1-activated Ca2+ responses of RBL-2H3 mast cells.
Lee RJ; Oliver JM
Mol Biol Cell; 1995 Jul; 6(7):825-39. PubMed ID: 7579697
[TBL] [Abstract][Full Text] [Related]
16. Stimulatory effect of pervanadate on calcium signals and histamine secretion of RBL-2H3 cells.
Teshima R; Ikebuchi H; Nakanishi M; Sawada J
Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):867-74. PubMed ID: 7524478
[TBL] [Abstract][Full Text] [Related]
17. Substantial depletion of the intracellular Ca2+ stores is required for macroscopic activation of the Ca2+ release-activated Ca2+ current in rat basophilic leukaemia cells.
Fierro L; Parekh AB
J Physiol; 2000 Jan; 522 Pt 2(Pt 2):247-57. PubMed ID: 10639101
[TBL] [Abstract][Full Text] [Related]
18. The effect of staurosporine on Ca2+ signals in rat basophilic leukemia (RBL-2H3) cells.
Teshima R; Ikebuchi H; Terao T; Nakanishi M
Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):747-51. PubMed ID: 2070459
[TBL] [Abstract][Full Text] [Related]
19. Effects of herbimycin A and ST638 on Fc epsilon receptor-mediated histamine release and Ca2+ signals in rat basophilic leukemia (RBL-2H3) cells.
Teshima R; Ikebuchi H; Sawada J; Furuno T; Nakanishi M; Terao T
Biochim Biophys Acta; 1994 Mar; 1221(1):37-46. PubMed ID: 7510521
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition, by loratadine and descarboxyethoxyloratadine, of histamine release from human basophils, and of histamine release and intracellular calcium fluxes in rat basophilic leukemia cells (RBL-2H3).
Berthon B; Taudou G; Combettes L; Czarléwski W; Carmi-Leroy A; Marchand F; Weyer A
Biochem Pharmacol; 1994 Mar; 47(5):789-94. PubMed ID: 7510965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
